Analyst Research

Report Title Price
Thomson Reuters Stock Report - ABAXIS, INC. (ABAX-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
ValuEngine Industry Report for Medical Products
Provider: ValuEngine, Inc.
$196.00
Buy
ABAXIS INC (ABAX) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Abaxis Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Abaxis, Inc. Announces Increase To Existing Share Repurchase Program


Thursday, 26 Jan 2012 04:01pm EST 

Abaxis, Inc. announced that the Board of Directors has approved a $15.0 million increase to its existing share repurchase program, to a total of $55.0 million. 

Latest Key Developments in Medical

Company Quote

Abaxis Inc
(ABAX.O)
44.22
-0.45 -1.01%
21 May 2013